Published April 12, 2023
| Version 1.0
Dataset
Open
The Origin and Clinical Benefit of First-in-Class Drugs that entered the French market between 2008 and 2018
Description
This file contains a data set of 135 First-in-class medicines that entered the French market between 2008 to 2018. For each drug we present data on provenance (inventor of the drug) and clinical benefit grading by Haute Autorité de Santé (HAS) and Prescrire. A legend on matching clinical grading scale can be found on tab 3 of the document.
Files
Files
(62.6 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:e566d39a08e9a8edbf290ada4a3b0012
|
62.6 kB | Download |